Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
CooperCompanies 4-for-1 Stock Split Effective Friday (2/16)
-
Navient declares first quarter common stock dividend
-
Employers Holdings, Inc. Reports Fourth Quarter 2023 and Full-Year Financial Results; Declares Quarterly Cash Dividend of $0.28 per Share
-
AMN Healthcare Announces Fourth Quarter and Full Year 2023 Results
-
Beamr Imaging Ltd. Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares
-
Post Holdings Announces Redemption of $459.3 Million 5.75% Senior Notes Due March 2027
-
Staffing 360 Solutions Shifts Strategy to Focus Exclusively on U.S. Staffing Industry; Divests U.K. Staffing Business
-
Lynch Carpenter Investigates Claims in Comcast Xfinity Data Breach
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Grupo Bafar Reports Fourth Quarter 2023 Results
-
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update
-
Trupanion Reports Fourth Quarter & Full Year 2023 Results
-
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
-
Backblaze Announces Fourth Quarter and Full Year 2023 Financial Results
-
Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
-
NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
-
Opendoor Announces Fourth Quarter and Full Year 2023 Financial Results
-
Financial Institutions, Inc. Announces Quarterly Cash Dividend
-
EuroDry Ltd. Reports Results for the Year and Quarter Ended December 31, 2023
-
Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024
-
ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications
-
Frontier Airlines to Participate in the Barclays Industrial Select Conference
-
Westrock Coffee Provides Business Announcements, Update on Preliminary 2023 Full Year Results, and Initial 2024 Outlook
-
Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event
-
Robinhood Markets, Inc. Reports January 2024 Operating Data
-
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification
-
Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
-
Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health
-
180 Degree Capital Corp. to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024, and to Host a Conference Call on Wednesday, February 21, 2024
-
LifeVantage Appoints Dayton Judd to the Board of Directors
-
Pactiv Evergreen Inc. Schedules Fourth Quarter 2023 Financial Results
-
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity
-
Texas Roadhouse, Inc. Announces Fourth Quarter 2023 Results
-
Shockwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results
-
Ottawa Bancorp, Inc. Announces Fourth Quarter and Fiscal 2023 Results
-
BJ’s Restaurants, Inc. Reports Fiscal Fourth Quarter and Fiscal 2023 Results
-
T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia
-
Freehold Royalties Ltd. Declares Dividend for February 2024
-
Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial
-
SÍL hs. - ákvörðun vaxta
-
Applied Materials Announces First Quarter 2024 Results
-
PDF Solutions® Reports Fourth Quarter and Full Year 2023 Results
-
Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
-
Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
-
Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs
-
Galapagos presents at EBMT-EHA annual meeting 2024
-
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update
-
Electrify Expo Expands for 2024 with Three New Cities, A Record Number of Tour Stops and Leading Brands Making Returns and Product Debuts
-
SBA Administrator Guzman Announces Important SBIC Program Milestones at White House Convening of Investment Industry Leaders

